E
bioAffinity Technologies, Inc. BIAF
$0.2872 -$0.0088-2.97% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income 10.33% -48.29% 5.19% -7.57% 17.34%
Total Depreciation and Amortization 0.65% 1.52% 0.13% 1.00% 0.54%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 39.51% 26.06% -35.12% 0.88% 20.98%
Change in Net Operating Assets -40.42% 2,086.78% -132.29% 117.20% -318.82%
Cash from Operations 2.11% 1.87% -11.54% 34.68% -45.15%
Capital Expenditure -- 100.00% 66.78% 31.64% -408.96%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- 100.00% 66.78% 31.64% -408.96%
Total Debt Issued -- -137.00% 29,200.00% -103.25% --
Total Debt Repaid -52.97% 0.00% -0.66% -1.92% -4.60%
Issuance of Common Stock -47.10% 47.28% -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- 200.00% --
Cash from Financing -49.06% 21.03% 1,937.43% -104.51% 2,480.90%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -289.45% 880.09% 97.29% -348.40% 78.17%